Denali Therapeutics
Denali Therapeutics is seeking a Principal Scientist to provide strategic technical leadership for late-phase and commercial analytical development of large molecule therapeutics. The role involves overseeing analytical method qualification, validation, and transfer activities at contract development and manufacturing organizations (CDMOs) while driving the implementation of analytical control strategies. This position requires hands-on laboratory execution, mentorship of junior colleagues, and collaboration with cross-functional teams to support accelerated CMC development and commercial timelines.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
Associate / Principal Scientist - Analytical Development
Elanco
Analytical Lead
Neurocrine Biosciences
Analytical Science and Technology (AS&T) Principal Scientist, Separation Method Expert
Vertex
Director, Analytical Research and Development CMC
Seaport Therapeutics
Senior Scientist, Analytical Development
Zymeworks
Process Development Sr. Scientist
Amgen